IL-1β transduces different signals than IL-1α leading to class II antigen expression on β-insulinoma RIN-5AH cells through specific receptors

Journal of Receptor and Signal Transduction Research

Volumn 17, Issue 1-3, 1997, Pages 211-225

  Vassiliadis, S ^a   Soteriadou, K P ^b   Papadopoulos, G K ^c  

^a UNIVERSITY OF CRETE   (Greece)

^b HELLENIC PASTEUR INSTITUTE   (Greece)

^c UNIVERSITY OF IOANNINA   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 2; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; NITRIC OXIDE; PROTEIN KINASE C; PROTEIN P21;

ANTIGEN EXPRESSION; CELL SURFACE; CONFERENCE PAPER; DOSE RESPONSE; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; INSULINOMA; RECEPTOR BINDING; RECEPTOR DENSITY; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION;

EID: 0031025767     PISSN: 10799893     EISSN: None     Source Type: Journal    
DOI: 10.3109/10799899709036605     Document Type: Conference Paper

References (22)

1. Dinarello, C.A. Interleukin-1 and interleukin-1 antagonism. Blood 77, 1627-1652, 1991.
2. Matsushima, K.; Akahoshi, T.; Yamada, M.; Furutari, Y.; and Oppenheim, J.J. Properties of a specific interleukin-1 (IL-1) receptor on human Epstein Barr virus-transformed B lymphocytes: identity of the receptor for IL-1α and IL-1β. J. Immunol. 136, 4496-4502, 1986.
3. Bristulf, J.; Gatti, S.; Malinowsky, D.; Sundgren, A.K.; and Bartfai, T. IL-1 stimulates the expression of type I and II IL-1 receptors in the rat insulinoma cell line Rinm5F; sequencing a rat type II IL-1 receptor cDNA. Eur. Cytokine Netw. 5, 319-330, 1994.
4. Dripps, D.J.; Branduber, B.J.; Thompson, R.C.; and Eisenberg, S.P. IL-1 receptor antagonist binds to the 80 RDa IL-1 receptor but does not initiate signal transduction. J. Biol. Chem. 266, 10331-10336, 1991.
5. McMahan, C.J.; Slack, J.L.; Mosley, B.; Cosman, D.; Luton, S.D.; Brunton, L.L.; Grubin, C.E.; Wignall, J.M.; Jenkino, N.A.; Brannan, C.L; Copeland, N.G.; Huebner, K.; Groce, C.M.; Cannizzarro, L.A.; Benjamin, D.; Dower, S.K.; Springs, M.K.; and Sims, J.E. A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types. EMBO J. 10, 2821-2832, 1991.
6. Eizirik, D.L.; Tracey, D.E.; Bendtzen, K.; and Sandler, S. An interleukin-1 receptor antagonist protein protects insulin-producing β-cells against suppressive effects of IL-1β. Diabetologia 34, 445-448, 1991.
7. Deyerle, K.L.; Sims, J.L.; Dower, S.K.; and Bothwell, M.A. Pattern of IL-1 receptor gene expression suggests role in non-inflammatory processes. J. Immunol. 149, 1657-1662, 1992.
8. Varey, A.M.; Lydyard, P.M.; Dean, B.M.; Van der Meide, P.H.; Baird, J.D.; and Cooke, A. IFN-γ induces class II MHC antigens on RINm5F cells. Diabetes 37, 209-212, 1988.
9. Chick, W.L.; Wawer, S.; Chute, R.N.; Like, A.A.; Lauris, V.; and Kitchen, K.C. A transplantable insulinoma in the rat. Proc. Natl. Acad. Sci. USA 74, 628-632, 1977.
10. Gadzar, A.F.; Chick, W.L.; and Oie, H.K. Continuous clonal insulin-and somatostatin-secreting cell lines established from a transplantable rat islet cell tumor. Proc. Natl. Acad. Sci. USA 77, 3519-3523, 1980.
11. Hunter, W.M.; and Greenwood, F.C. Preparation of iodine-131 labeled human growth hormone of high specific activity. Nature 194, 495-496, 1962.
12. Dower, S.K.; Kronheim, S.R.; Hopp, T.P.; Cantrell, M.; Deeley, M.; Gillis, S.; Henney, C.S.; and Urdal, D.L. The cell surface receptors for IL-1α and IL-1β are identical. Nature 324, 266-268, 1986.
13. Voyiatzaki, C.S.; and Soteriadou, K.P. Evidence of transferrin binding sites on the surface of Leishmania promastigotes. J. Biol. Chem. 265, 22380-22386, 1990.
14. Vassiliadis, S.; Guilbert, L.J.; Kyrpides, N.; and Papamatheakis, J. Different molecular mechanisms lead to same endpoints with different function: TNF-α induces non-functional CSF-1 receptors on HL-60 cells in contrast to IFN-γ. J. Receptor Res. 12, 59-70, 1992.
15. Munson, P.G.; and Rodbard, D. LIGAND: A versatile computerized approach for characterization of ligand-binding systems. Analyt. Biochem. 107, 220-239, 1980.
16. Vassiliadis, S.; and Papadopoulos, G.K. IL-6-mediated MHC class II induction on RIN-5AH insulinoma cells by IFN-γ occurs via the G-protein pathway. Med. Inflamm. 4, 374-379, 1995.
17. Todd, J.A.; Acha-Orbea, H.; Bell, J.I; Chao, N.; Fronek, Z.; Jacob, C.O.; McDermott, M.; Sinha, A.A.; Timmerman, L.; Steinman, L.; and McDevitt, H.O. A molecular basis for MHC class II associated autoimmunity. Science 240, 1003-1009, 1988.
18. Mitlianga, P.G.; Germanidis, G.S.; Moutsopoulos, H.M.; and Papadopoulos, G.K. The effect of TGF-β1, and TNF-α on the cytotoxic/cytostatic action of interleukin-1 (α and β isoforms) on the pancreatic β cell line RIN-5AH. Int. J. Immunopathol. Pharmacol. 8, 67-77, 1995.
19. Palmer, J.; Helqvist, S.; Spinas, G.A.; Molrig, J.; Mandrup-Poulsen T.; Andersen, H.U.; and Nerup, J. The beta cell-a moving target? Interaction between pancreatic beta cell activity, IL-1 concentration, and IL-1 exposure on insulin secretion from isolate rat islets of Langerhans. Diabetes 38, 1211-1216, 1989.
20. Corbert, T.; Wang, J.L.; Misko, T.P.; Zhao, W.G.; Hickey, W.F.; and McDaniel, M.L. Nitric oxide mediates IL-1β-induced islet dysfunction and destruction - Prevention by dexamethasone. Autoimmunity 15, 145-152, 1993.
21. Linge, C.; and Green, M.R. In: Growth factors-A practical approach, edited by I. McKay and I. Leigh, p. 201-236, Oxford University Press, Oxford, 1993.
22. Kolb, H.; and Kolb-Bachofen, V. Nitric oxide: a pathogenic factor in autoimmunity. Immunol. Today 13, 157-160, 1992.